8-K filing — Definitive Healthcare Corp. (DH)
Filed: 2026-09-09 AccNo: 0001193125-26-385950 Size: 160 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Definitive Healthcare shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised its FY26 adjusted EPS guidance.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Definitive Healthcare shares are trading higher after the company confirmed the receipt of going-private proposal from Advent International. The company also announced the appointment of Clay Ritchey as its CEO.
Definitive Healthcare Special Committee Says It Received Non-Binding Indication Of Interest From Advent International To Take The Company Private And Acquire All Outstanding Class A Shares For $1.02/Share In Cash
Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop
Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the